Skip to content

Watch live
Watch live
SOCI - Standing Committee

Social Affairs, Science and Technology

Past Session: Past Session:
41-2 41st Parliament, 2nd Session (October 16, 2013 - August 2, 2015)
Select a different session
Download as PDF

Proceedings of the Standing Senate Committee on
Social Affairs, Science and Technology

Second Session, Forty-first Parliament, 2013-14

Chair: The Honourable KELVIN KENNETH OGILVIE

Wednesday, June 4, 2014
Thursday, June 5, 2014
Friday, June 6, 2014

Issue No. 16

First (final) meeting on:

Bill S-211, An Act to establish a national day to promote health and fitness for all Canadians

First and second (final) meetings on:

Bill S-5, An Act to amend the Canada National Parks Act (Nááts'ihch'oh National Park Reserve of Canada)

Twentieth meeting on:

Study on prescription pharmaceuticals in Canada

INCLUDING:
THE TENTH REPORT OF THE COMMITTEE
(Bill S-211)

THE ELEVENTH REPORT OF THE COMMITTEE
(Bill S-5)

WITNESSES

Wednesday, June 4, 2014

The Honourable Senator Nancy Greene Raine, sponsor of Bill S-211.

Government of the Northwest Territories:

Peter Vician, Deputy Minister of Industry, Tourism and Investment (by video conference).

Thursday, June 5, 2014

Canadian Parks and Wilderness Society:

Alison Woodley, National Director, Parks Program.

Parks Canada:

Darlene Pearson, Director, Policy, Legislative and Cabinet Affairs Branch, Strategy and Plans Directorate;

Kevin McNamee, Director, Protected Areas Establishment Branch.

Department of Justice Canada:

Sonja Beharry, Legal Counsel, Environment (Parks Canada) Legal Services.

Friday, June 6, 2014

Canadian Institute for Health Information:

Michael Gaucher, Director, Pharmaceuticals and Health Workforce Information Services.

Canada Health Infoway:

Jennifer Zelmer, Senior Vice-President, Clinical Adoption and Innovation.

Canadian Agency for Drugs and Technologies in Health:

Brian O'Rourke, President and Chief Executive Officer.

Canadian Pharmacists Association:

Perry Eisenschmid, Chief Executive Officer.

HealthCareCAN (formerly ACAHO-CHA):

Tina Saryeddine, Assistant Vice-President, Research and Policy Analysis.

Institute for Clinical Evaluative Sciences:

Dr. David Juurlink, Head, Division of Clinical Pharmacology and Toxicology, Sunnybrook Health Sciences Centre.

Psychiatric Medication Awareness Group:

Janet Currie, Representative.

Canadian Organization for Rare Disorders:

Maureen Smith, Secretary.

Canadian Institutes of Health Research:

Dr. Robert Peterson, Executive Director, Drug Safety and Effectiveness Network.

Institutional Review Board Services:

Jack Corman, President.

Rx&D:

Jared Rhines, Vice-president, Scientific and Strategic Affairs.

As individuals:

Ronald Heslegrave, Executive Director, William Osler Health System.

Amir Attaran, Canadian Research Chair, Population Health and Global Development Policy, University of Ottawa.

Mary Wiktorowicz, Chair and Associate Professor, School of Health Policy & Management, Faculty of Health, York University.

Matthew Herder, Assistant Professor, Health Law Institute, Faculties of Medicine and Law, Dalhousie University.

Canadian Generic Pharmaceutical Association:

Dr. Colin D'Cunha, Director, Global Medical Affairs, Apotex Inc.

MEMBERS OF THE COMMITTEE

The Honourable Kelvin Kenneth Ogilvie, Chair

The Honourable Art Eggleton, P.C., Deputy Chair

and

The Honourable Senators:

*Carignan, P.C. (or Martin), Chaput, Cordy, *Cowan (or Fraser), Eaton, Enverga, Munson, Nancy Ruth, Segal, Seidman, Seth, Stewart Olsen

* Ex officio members

(Quorum 4)

Changes in membership of the committee:

Pursuant to rule 12-5, membership of the committee was amended as follows:

The Honourable Senator Enverga replaced the Honourable Senator Patterson (June 5, 2014).

The Honourable Senator Patterson replaced the Honourable Senator Enverga (June 4, 2014).

Back to top